Evofem Biosciences Inc (ID) (EVFM)

HUB Cyber Security Expands Into Women’s Health With Zero-Cash Acquisition of Evofem Notes, Advances Balance Sheet Turnaround

TEL AVIV, Israel, July 01, 2026 (GLOBE NEWSWIRE) -- HUB Cyber Security Ltd. (Nasdaq: HUBC) (“HUB” or the...

Form 8-K - Current report

Evofem Reports First Quarter 2026 Financial Results and Provides Business Update

— Advancing Strategy to Increase and Diversify Revenue through Ex-U.S. Commercialization — Women’s health innovator Evofem Biosciences, Inc...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Evofem Announces Exclusive Agreement for the Distribution and Commercialization of SOLOSEC in Sub-Saharan Africa

— SOLOSEC® (secnidazole) 2g Oral Granules is an FDA-Approved Single-Dose Oral Treatment for Bacterial Vaginosis and Trichomoniasis — Women’s...

Form 8-K - Current report

Form 8-K - Current report

Form 8-K - Current report

Evofem Reports Fifth Consecutive Year of Net Sales Growth

— Net sales surpassed $20 million mark in FY 2025 — — Income from operations increased to $3.4 million in FY 2025 — Women’s health innovator...

Evofem CEO Saundra Pelletier Calls for a “Ground-Up Reset” of Women’s Health at Fierce JPM Week 2026

Pelletier’s provocative keynote at Fierce JPM 2026 explores how moving beyond legacy models can drive progress in women’s health Women's health...

Evofem Expands “Say Vagina” Campaign With Launch of Say Vagina Store

Evofem Biosciences, Inc. (“Evofem” or the “Company”) (OTCID: EVFM) today announced the launch of the Say Vagina Store, expanding its...

Form 8-K - Current report

Form 8-K - Current report

Form 8-K - Current report